Measured vs matched controls · Top-10 global pharma

$32.2M in AI-driven
field sales. +91% TRx vs matched controls.

The intelligence layer for pharma GTM. Five accelerators, two platforms — in production across 10+ brands and 350+ field and HQ users.

Measured independently · Definitive Healthcare
Pharma commercial team reviewing field impact together
Cited answer · 90 seconds
80+
Models in production
12 weeks
First use case live, embedded team
SOC 2
Type II · HIPAA-aligned
Our team has shipped AI at Merck Daiichi Sankyo Organon Biocon Siemens Healthineers
AI Accelerators

The Future of Pharma
Commercial AI

Five AI accelerators. Two platforms. Every one in production across 10+ brands.

PrismAnalytics

Patient-data enrichment for claims & EHR

SageField & HQ

Conversational intelligence for field & HQ

HorizonForecasting

Patient-based forecasting for brand & S&OP

QuillContent

Evidence-linked content for brand teams

AtlasLaunch

KOL and competitive intelligence for launch teams

Sage · Rep Intelligence

Ask your commercial data anything

Which oncology HCPs shifted to second-line therapy this quarter?You
128 physicians moved ≥3 patients to 2L — 41 unseen by the field in 60 days. Ranked list and visit prep attached, every number cited to source.
Ask about your brand…
Platform

Built from the ground up for pharma commercial

Deploy a single accelerator, a set of components, or the full platform — start where the value is, scale on the same foundation.

Trusted where it counts — in production

Enrichment recovered invisible patients. Models re-ranked the call plans. Reps acted — and impact was measured continuously against matched controls, independently, not self-reported.

Field impact, one franchiseMeasured by Definitive Healthcare
Top-10 global pharma
$32.2MAI-driven field sales, one franchise
+91% TRxper targeted physician vs matched control

First drafts 70% complete, in hours. Every claim traceable to its source page — hallucination detection and numerical fact-checks built in. Live across AMNOG and GRD; filings land months sooner.

Dossier authoring at scaleAMNOG & GRD submissions
Global pharma, EU & US
€240K+saved per AMNOG dossier
€4MNPV per month from filing sooner

Commercial AI metrics from live production deployments with Top-10 global pharma — field impact independently measured against matched controls by Definitive Healthcare. Detailed case studies available under NDA.

FDE Services

Embedded teams. Impact from day one.

Pharma experts and engineers embedded with your teams — from first assessment to scaled deployment, with transparent pricing.

The Akaike team at their office
01

Assess

Your AI capabilities scored use case by use case — basic to advanced — so you know exactly where you stand.

02

Roadmap

A phased plan with value gates — sequenced to what your organisation can absorb.

03

Embed

A forward-deployed team inside your workflow — pharma operators and engineers, not a ticket queue.

04

Ship

First use case live in production in under 12 weeks — on your data, in your stack.

05

Prove

Impact measured against matched controls — then expand what works to the next use case.

Maturity assessment Roadmapping with value gates Transparent pricing
Start with an assessment

The future of pharma GTM
starts with intent.

reach@akaiketech.com hello@intentpi.com